July 2024

New guidance: 

Updated Guidance: 

Changes to guidance are listed in the 'What's new' section of each guideline. 

Removed guidance: 

  • Hospital in-patients admitted with symptomatic COVID-19 infection (Guidelines)
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection (Guidelines)
  • Highest Risk List: COVID-19 (Guidelines):
    Replaced by: Risk factors for progression to severe COVID-19 infection | Right Decisions (scot.nhs.uk)
  • Community Pharmacy (Resources):
    Archived as information now available on CP website. 
  • Allergy (Paediatric guidelines):
    Replaced by Food allergy referral and Egg allergy guidelines. 
  • Epidural (Paediatric Guidelines) | Right Decisions (scot.nhs.uk)

June 2024

New guidance:

Updated guidance: 

Guidance reviewed with no changes: 

Removed guidance: 

  • Referral to clinical Psychology (Guidelines)
  • Orlistat Frequently Asked Questions (Patient information)
  • Bariatric Surgery Frequently Asked Questions (Patient information)
  • Non-steroidal anti-inflammatory drugs (NSAIDS) (Guidelines)
  • Self Help Service - patient information leaflet (Guidelines)

May 2024

New Guidance:

Updated Guidance: 

Removed Guidance:

  • Anticoagulant recommendations. This is replaced with: Warfarin. 

April 2024

New Guidance

Updated Guidance (with changes)

Updated Guidance (no changes)

Removed Guidance 

  • COVID115 Management of surgical patients who decline a COVID19 test
  • AMT136 Prophylaxis following tick bite
  • AMT137 Erythema migrans (EM) and/or non-focal symptoms (eg 'flu-like' symptoms)
  • AMT138 Lyme disease affecting the cranial nerves or peripheral nervous system
  • AMT139 Lyme disease affecting the central nervous system
  • AMT140 Lyme disease arthritis, Acrodermatitis chronic atrophicans
  • AMT141 Lyme carditis: haemodynamically stable
  • AMT142 Lyme carditis: haemodynamically unstable

March 2024

New guidance

  • Haematology Full guideline suite reviewed with updates to guidelines and new guidelines added: 
    • Thrombocytopenia
    • Neutropenia
    • Neutrophilia
    • Lymphocytosis
    • Eosinophilia
    • Basophilia
    • Monocytosis
    • Splenomegaly
    • Lymphadenopathy
    • Elevated plasma viscosity
    • Iron deficiency
    • Hyperferritinaemia
    • Abnormal coagulation screen and bruising
    • VTE and travel
    • Blood parasite investigation
  • ADHD Guidelines

Updated guidance

Removed guidance

  • ADHD Pilot Pathway 
  • Post partum haemorrhage 
  • Physical monitoring with mental health

February 2024

Updated guidance

Removed guidance

  • Introduction to treatment of low electrolytes as the information is within the guidance

January 2024

Updated Guidance

2023

January 2023:

New guidance

  • TAM535 ADHD pilot pathway

Amended guidance 

  • TAM528 Delirium management
  • TAM281 Parkinsons disease
  • TAM148 Achieving control in type 2 diabetes
  • TAM481 Giant cell arthritis (GCA)
  • TAM331 Non-IgE Cows Milk Protein Allergy Guidance 
  • TAM135 Acute coronary care syndrome
  • AMT101 Amikacin
  • AMT152 Influenza treatment
  • Urinary tract (UTI)
  • TAM508 Pre-Diabetes and type 2 referrals

Removed guidance 

  • COVID078 Emergency management of tracheostomy patient on LTV 
  • COVID019 Rheumatology COVID-19
  • COVID102 Anticoagulant COVID-19
  • COVID004 Cancer COVID-19
  • COVID052 End of life Acute COVID-19
  • COVID006 Diabetes COVID-19 
  • TAM302 Management following colposcopy 
  • TAM299 Cervical smear recall 
  • TAM387 Incontinence dermatitis
  • FCR110 Inner Moray Firth Investigation and Treatment Room Service 
  • COVID021 SKIN COVID-19
  • COVID020 Sexual Health
  • COVID013 Mental Health COVID-19

February 2023:

NB this section is being updated on a daily basis throughout the month.

New guidance

  • Refugee and asylum seeker support
  • Protocol for the administration of intravenous mannitol to reduce raised intra-ocular pressure

Amended guidance 

  • TAM310 GP Out of Hours HSCP
  • COVID111 Non hospitalised patients with symptomatic COVID-19 infection 
  • COVID039 Aeroso generating procedures
  • TAM185 Ophthalmology diagnosis/flowcharts 
  • TAM148 Achieving control in type 2 diabetes 
  • TAM UTI guidance 

March 2023:

New guidance

  • ADHD pilot pathway

Updated guidance

  • Stress and distress in dementia

Removed guidance

  • Incontinence dermatitis
  • Skin COVID-19
  • Sexual Health COVID-19

April 2023:

New guidance

  • Protocol for the administration of intravenous mannitol to reduce raised intra-ocular pressure
  • VTEP guidance: New Craigs

Updated guidance

  • Aerosol generating procedures COVID-19
  • Eyes
  • Genital tract
  • Highest Risk List: COVID-19
  • HIV pre-exposure prophylaxis PrEP
  • Infective endocarditis
  • Influenza treatment
  • Microbiology susceptibility reporting
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Smoking cessation
  • Ultrasound referral guidelines
    • Neck lump added

Removed guidance

  • Long term ventilation: Primary Care: COVID-19

May 2023:

New guidance

  • ECG monitoring of patient on drugs known to prolong the QT interval
  • Gender identity guidance
  • Palpable cervical lymph nodes (paediatrics)
  • Ultrasound follow-up of gall bladder polyp
  • Vancomycin in haemodiafiltration

Updated guidance

  • Chronic and persistent pain

June 2023:

Updated guidance

  • Hyperkalaemia
  • FAQ for GP CT Referral for Cancer
  • Imaging pathway for Primary Care direct access to CT chest/abdomen/pelvis for suspected malignancy
  • Ophthalmology referral guidelines, including Out of Hours
  • Ophthalmology emergency admission protocol: Raigmore and NTC
  • Orbital cellulitis
  • Lower limb lymphoedema
  • Upper Limb lymphoedema
  • Age-related macular degeneration (nhsh.scot)
  • Patient information - Stroke (nhsh.scot)
  • Imaging pathway for Primary Care direct access to CT chest/abdomen/pelvis for suspected malignancy (nhsh.scot)
  • FAQ for GP CT Referral for Cancer Pathway (nhsh.scot)
  • Referral to Community Diabetes Specialist Nurses (nhsh.scot)

July 2023:

Updated guidance

  • Sayana Press
  • Armed forces and veterans 

August 2023:

New Guidelines

  • Major haemorrhage protocol 

Updated Guidelines 

  • Computerised cognitive behaviour (cCBT) 
  • Referral to community diabetes
  • FAQ for GP CT Referral for cancer pathway 
  • Imaging pathway for Primary Care direct access
  • Age related macular degeneration 
  • Patient information stroke 
  • Hyperkalaemia
  • Colorectal investigation and referral
  • Incorrect use of combined hormonal contraception 
  • Acute treatment and secondary prevention of transient ischaemic attacks (TIA) and ischaemic stroke 
  • Adrenarche
  • Sleep onset difficulties 

September 2023:

New guidance:

  • Oral buprenorphine in opioid dependence (Guidelines) 
  • Medication assisstend treatment (MAT) (Guidelines)

Updated Guidance:

  • Malignant spinal cord compression
  • Uncomplicated chlamydia in Primary Care
  • Patient information stroke 
  • Acute treatment and secondary prevention of transient ischaemic attacks (TIA) and ischaemic stroke
  • Management of children under 16yrs under the influence of drugs/alcohol 
  • Improving the Safety of Patients with a Tracheostomy
  • Ultrasound scan (USS) referral guidelines 

October 2023:

New guidance

  • Personality disorder integrated care pathway

Updated guidance

  • Prolonged seizure / status epilepticus in adults (Primary Care)
  • Osteoporosis
  • Computerised cognitive behavioural therapy (cCBT) 
  • Glucose monitoring
  • Red eye
  • Gender identity guidance 
  • Corticosteroids (dexamethasone, prednisolone and hydrocortisone for patients confirmed SARS-CoV-2 infection
  • Acute otitis media 
  • Acute otitis externa
  • Tuberculosis
  • Acute Coronary Syndrome
  • Emergency contraception 
  • Heart Failure assessment and investigations
  • Heat Failure diagnosis 
  • Heart Failure Medical management
  • Heart Failure Management of decompensation 
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection
  • Lymphopenia assessment
  • ED Stroke Thrombolysis 
  • Ophthalmology referral guidelines, including Out of Hours 
  • Treatment COVID19
  • Antivirals and neutralising monoclonal antibodies COVID19
  • Hospital in-patient Tocilixumab and Sarilumab
  • Generalised anxiety disorder
  • Depression

November2023: 

Updated Guidance

  • Gender identity guidance (Guidelines) | Right Decisions (scot.nhs.uk)
  • Acute coronary syndrome
  • Highland Eating Disorder Service (HEDS) & Medical Emergency Eating Disorder (MEED)
  • Hospital in-patient with hospital-acquired/hospital onset COVID-19 infection 
  • Non-hospitalised patients with symptomatic COVID-19 infection
  • Chronic Kidney Disease 
  • Acute Kidney Injury
  • Polycythaemia erythrocytosis
  • Psychotic Disorders
  • Thrombocytosis
  • Post-menopausal bleeding

December 2023: 

Updated Guidance

  • Feeling of lump in throat
  • Vascular
  • Treatment COVD19
  • Female urinary incontinence

2022

September 2022:

New guidance:

  • Short synacthen test
  • Resuscitation
  • Hypercalcaemia
  • Plasma metanephrines measurement
  • Delirium management
  • Child healthy weight
  • Faecal incontinence
  • Investigation of primary hyperaldosteronism

Updated guidance:

  • SGLT2 inhibitors type 2 diabetes

Guidance removed:

  • Toddler and young children; food, mood and health guidance

October 2022:

New guidance:

  • Colorectal secondary guidance

Updated guidance:

  • Testosterone replacement in menopause TAM492 
  • Gestational diabetes
  • Computerised cognitive behaviour (cCbt)
  • Folate testing and management
  • B12 deficiency testing and management
  • Children empirical antibiotic therapy
  • Intermittent claudication/critical ischaemia
  • Baricitinib for adults and children aged 2 years and older
  • Clostridium dificile
  • NTproBNP
  • Pre diabetes and type 2 diabetes referrals

Guidance removed:

  • Toddler and young children food mood and health guidance 

 

November 2022:

New guidance:

  • Bronchiolitis 
  • Emergency admission of adults with acute constipation
  • Groin hernia pathway 
  • Gallstone disease 
  • Anti reflux surgery

Updated guidance:

  • Amputation pain Raigmore
  • Ketamine
  • Teicoplanin
  • Gentamicin dosing in infective endocarditis in adults 
  • Naloxone and managing opioid
  • Post operative nausea and vomiting
  • Patient controlled analgesia PCA 
  • Subcutaneous opioid
  • Epidural analgesia
  • Local anaesthetic infusion
  • Wet legs lymphorrehoea

Guidance removed: 

  • None 

December 2022:

New Guidance: 

  • Silver Diamine fluoride
  • Bronchiolitis 
  • Raigmore emergency ophthalmology admission protocol

Updated Guidance: 

  • Pre diabetes and type 2 diabetes referrals
  • Testosterone replacement in menopause
  • Gentamicin
  • Subcutaneous Methotrexate
  • Highland eating disorder (HEDS) and MEED 
  • Subcutaneous opioids
  • Acute pain management in adults with renal impairment
  • Epidural analgesia 
  • Assessing vascular status
  • Wet legs lymphorrhoea
  • Ketamine infusion
  • Amputation
  • Pain assessment
  • Pain controlled analgesia
  • Post operative nausea and vomiting 
  • Naloxone and managing opioid
  • Local anaesthetic infusion 

Removed guidance: 

  • Information for patients, carers and families 
  • Treatment of medically unwell patients with anorexia nervosa 
  • MARSIPAN checklist 
  • Summary of a dieticians role 
  • Increased levels of care